Home  |  Contact

UniProtKB/Swiss-Prot P14653: Variant p.Arg207Cys

Homeobox protein Hox-B1
Gene: HOXB1
Variant information

Variant position:  207
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Arginine (R) to Cysteine (C) at position 207 (R207C, p.Arg207Cys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (C)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Facial paresis, hereditary congenital, 3 (HCFP3) [MIM:614744]: A form of facial paresis, a disease characterized by isolated dysfunction of the facial nerve (CN VII). HCFP3 patients are affected by bilateral facial palsy, facial muscle weakness of muscles innervated by CN VII, hearing loss, and strabismus. {ECO:0000269|PubMed:22770981}. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In HCFP3; decreased transactivation activity at low DNA concentrations; increased transactivation activity at high DNA concentrations compared to wild-type.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  207
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  301
The length of the canonical sequence.

Location on the sequence:   RNPPKTAKVSEPGLGSPSGL  R TNFTTRQLTELEKEFHFNKY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RNPPKTAKVSEPG-LGSPSGLRTNFTTRQLTELEKEFHFNKY

Rhesus macaque                RNPPKTGKVSEPG-LGSPSGLRTNFTTRQLTELEKEFHFNK

Chimpanzee                    RNPPKTAKVSEPG-LGSPSGLRTNFTTRQLTELEKEFHFNK

Mouse                         RNPPKTAKVSELG-LGAPGGLRTNFTTRQLTELEKEFHFNK

Chicken                       RNPPKTAKVSEYGLLGQPNTIRTNFTTKQLTELEKEFHFNK

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 301 Homeobox protein Hox-B1
DNA binding 203 – 262 Homeobox
Alternative sequence 193 – 232 AKVSEPGLGSPSGLRTNFTTRQLTELEKEFHFNKYLSRAR -> GRAQMWPPLLRGPKHLCFPCSDMSWVWAGFFSFSGSGRHR. In isoform 2.


Literature citations

HOXB1 founder mutation in humans recapitulates the phenotype of Hoxb1(-/-) mice.
Webb B.D.; Shaaban S.; Gaspar H.; Cunha L.F.; Schubert C.R.; Hao K.; Robson C.D.; Chan W.M.; Andrews C.; Mackinnon S.; Oystreck D.T.; Hunter D.G.; Iacovelli A.J.; Ye X.; Camminady A.; Engle E.C.; Jabs E.W.;
Am. J. Hum. Genet. 91:171-179(2012)
Cited for: VARIANT HCFP3 CYS-207; CHARACTERIZATION OF VARIANT HCFP3 CYS-207;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.